多支胫动脉血运重建未改善重症肢体缺血患者结局
基于血管质量倡议(VQI)注册数据,纳入761条患有多支胫动脉病变的重症肢体缺血(CLI)肢体,比较单支与多支(≥2支)胫动脉腔内介入的成功血运重建。结果显示两组大截肢率(9.0% vs 7.6%,P=.6)和1年无截肢生存率(90.6% vs 92.9%,P=.372)无差异,多变量Cox模型中仅通畅性丧失可预测大截肢。
要点
- 多支胫动脉病变CLI患者中,单支与多支血运重建的大截肢率和1年无截肢生存率无显著差异
- 介入前组织缺损并非未来大截肢的预测因素(亚组分析355例)
核心结论
- 在VQI注册中,多支胫动脉闭塞性病变的CLI患者,多支胫动脉血运重建相比单支血运重建未显示保肢获益。
研究设计与样本
- 回顾性注册研究,使用血管质量倡议(VQI)数据库,评估2002至2017年多支胫动脉病变的CLI患者。
- 共10849例CLI患者,其中761条肢体具备充分围术期数据和临床随访纳入分析。
- 按成功血运重建的胫动脉支数分为单支组(SV,473条,62.1%)和多支组(MV,288条,37.9%)。
- 主要结局为无截肢生存率,平均随访337±62天。
主要发现
- MV组患者更年轻(69.1 vs 73.2岁;P<.001),吸烟率更高(29.5% vs 18.2%;P<.001)。
- SV组更常同期行股动脉或腘动脉流入道介入(83.7% vs 78.1%;P=.05)。
- MV组完成时多支流出道通畅显著更高(99.9% vs 39.9%;P<.001)。
- 两组大截肢率无差异(9.0% vs 7.6%;P=.6),1年无截肢生存率相似(90.6% vs 92.9%;P=.372)。
关键数值与推荐
- 大截肢率:SV组9.0%,MV组7.6%(P=.6)。
- 1年无截肢生存率:SV组90.6%,MV组92.9%(P=.372)。
临床怎么用
- 对多支胫动脉病变的CLI患者,可优先考虑单支胫动脉血运重建,多支重建未显示额外保肢获益。
- 术后应重视监测血运重建血管的通畅性,通畅性丧失与大截肢风险显著相关。
局限性
- 研究为回顾性注册分析,仅761条肢体(占10849例的少数)具备充分数据和随访。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Multivessel tibial revascularization for critical limb ischemia (CLI) remains controversial. The purpose of this study was to evaluate single vs multiple tibial vessel interventions in patients with multivessel tibial disease. We hypothesized that there would be no difference in amputation-free survival between the groups. METHODS: Using the Vascular Quality Initiative registry, we reviewed patients undergoing lower extremity endovascular interventions involving the tibial arteries. Patients with CLI were included only if at least two tibial vessels were diseased and adequate perioperative data and clinical follow-up were available for review. The primary outcome was amputation-free survival. RESULTS: There were 10,849 CLI patients with multivessel tibial disease evaluated from 2002 to 2017; 761 limbs had adequate data and follow-up available for review. Mean follow-up was 337 ± 62 days. Of these, 473 (62.1%) underwent successful single-vessel tibial intervention (group SV), whereas 288 (37.9%) underwent successful multivessel (two or more) intervention (group MV). Patients in group MV were younger (69.1 vs 73.2 years; P < .001), with higher tobacco use (29.5% vs 18.2%; P < .001). Group SV more commonly had concurrent femoral or popliteal inflow interventions (83.7% vs 78.1%; P = .05). Multivessel runoff on completion was significantly greater for group MV (99.9% vs 39.9%; P < .001). No differences were observed between group SV and group MV for major amputation (9.0% and 7.6%; P = .6), with similar amputation-free survival at 1 year (90.6% vs 92.9%; P = .372). In a multivariate Cox model, loss of patency was the only significant predictor of major amputation (hazard ratio, 5.36 [2.7-10.6]; P = .01). A subgroup analysis of 355 (46.6%) patients with tissue loss data showed that tissue loss before intervention was not predictive of future major amputation. CONCLUSIONS: In the Vascular Quality Initiative registry, patients with CLI and occlusive disease involving multiple tibial vessels did not appear to have a limb salvage benefit from multiple tibial revascularization compared with single tibial revascularization.
引用
- Lavingia KS, Tran K, Dua A, et al. Multivessel tibial revascularization does not improve outcomes in patients with critical limb ischemia. J Vasc Surg. 2019. PMID: 31685281. doi:10.1016/j.jvs.2019.08.251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。